AnvirzelTM modulates the Akt/mTOR pathway, activates ERK and mTOR phosphorylation, decreases Akt and JNK1/2 phosphorylation in human glioblastoma cells U-87 MG after 48 h. The gene discussed is AKT1; the disease is glioblastoma.